Literature DB >> 16458967

Patient-reported behavior and problems in using glaucoma medications.

Betsy Sleath1, Alan L Robin, David Covert, John E Byrd, Gail Tudor, Bonnie Svarstad.   

Abstract

OBJECTIVE: The objectives of the current study were to describe the different types of problems patients receiving adjunctive therapy reported having when taking their glaucoma medications and to examine the relationship between patient-reported problems in taking their glaucoma medications and patient adherence.
DESIGN: Cross-sectional survey. PARTICIPANTS: A survey was distributed to glaucoma patients in 4 geographically distinct ophthalmology practices. We excluded patients using only 1 glaucoma medication. The survey was completed by 324 patients.
METHODS: For each patient, average percent adherence to his or her glaucoma medication regimen was calculated. Logistic regression was used to examine how patient characteristics and problems in using glaucoma medications were related to reported adherence. MAIN OUTCOME MEASURE: Whether patients were less than 100% adherent in the previous week.
RESULTS: We found that 60% of patients reported 1 or more problems with taking their glaucoma medications. Fourteen percent of patients reported being less than 100% adherent to their glaucoma regimen medications during the previous week. Patients who had difficulty remembering to take their glaucoma medications and those who reported that they had other problems or concerns with their glaucoma medications were significantly less likely to be 100% adherent.
CONCLUSIONS: Patient adherence to a glaucoma medication regimen could be improved among patients receiving adjunctive therapy. Ophthalmologists and their clinical colleagues should make sure to discuss the problems and concerns that patients may have in taking their glaucoma medications in an effort to improve adherence.

Entities:  

Mesh:

Year:  2006        PMID: 16458967     DOI: 10.1016/j.ophtha.2005.10.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  92 in total

1.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

2.  Glaucoma patient expression of medication problems and nonadherence.

Authors:  Catherine Slota; Robyn Sayner; Michelle Vitko; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Betsy Sleath
Journal:  Optom Vis Sci       Date:  2015-05       Impact factor: 1.973

3.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

4.  Persistence with topical glaucoma therapy among newly diagnosed Japanese patients.

Authors:  Kenji Kashiwagi; Toshie Furuya
Journal:  Jpn J Ophthalmol       Date:  2013-10-25       Impact factor: 2.447

5.  Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination.

Authors:  Eric Sellem; Jean François Rouland; Christophe Baudouin; Alain Bron; Philippe Denis; Jean-Philippe Nordmann; Jean Paul Renard
Journal:  BMC Ophthalmol       Date:  2010-03-26       Impact factor: 2.209

6.  Combination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysis.

Authors:  Manuele Michelessi; Kristina Lindsley; Tsung Yu; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2014-11

7.  Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.

Authors:  Jack Stringham; Noy Ashkenazy; Anat Galor; Sarah R Wellik
Journal:  Eye Contact Lens       Date:  2018-01       Impact factor: 2.018

8.  Considerations in glaucoma therapy: fixed combinations versus their component medications.

Authors:  Eve J Higginbotham
Journal:  Clin Ophthalmol       Date:  2010-02-02

9.  Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment.

Authors:  Antoine Regnault; Muriel Viala-Danten; Hélène Gilet; Gilles Berdeaux
Journal:  BMC Ophthalmol       Date:  2010-02-01       Impact factor: 2.209

10.  Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden.

Authors:  Anders Bergström; Frédérique Maurel; Claude Le Pen; Emilie Lamure; Michael Kent; Isabelle Bardoulat; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.